Viera Muzithras
Algemeen Adviseur bij TCR2 THERAPEUTICS INC.
Profiel
Viera Muzithras is currently the Vice President-Regulatory Affairs at TCR2 Therapeutics, Inc. Prior to this, he worked as an Executive Director-Global Regulatory Affairs at Bristol Myers Squibb Co. and as a Senior Director-Regulatory Affairs at Novartis Pharmaceuticals Corp.
from 2008 to 2016.
He obtained his undergraduate degree from Rutgers State University of New Jersey.
Actieve functies van Viera Muzithras
Bedrijven | Functie | Begin |
---|---|---|
TCR2 THERAPEUTICS INC. | Algemeen Adviseur | 27-05-2020 |
Eerdere bekende functies van Viera Muzithras
Bedrijven | Functie | Einde |
---|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Public Communications Contact | 01-07-2016 |
BRISTOL-MYERS SQUIBB COMPANY | Algemeen Adviseur | - |
Opleiding van Viera Muzithras
Rutgers State University of New Jersey | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |